Pieris Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 17.0
| PIRS Stock | USD 16.43 0.18 1.11% |
Pieris |
Pieris Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pieris Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pieris Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pieris Pharmaceuticals generated a negative expected return over the last 90 days | |
| Pieris Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 42.81 M. Net Loss for the year was (24.54 M) with loss before overhead, payroll, taxes, and interest of (27.08 M). | |
| Pieris Pharmaceuticals currently holds about 80.94 M in cash with (53.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09. | |
| Pieris Pharmaceuticals has a poor financial position based on the latest SEC disclosures |
Pieris Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pieris Stock often depends not only on the future outlook of the current and potential Pieris Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pieris Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 26.4 M |
Pieris Pharmaceuticals Technical Analysis
Pieris Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Pieris Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pieris Pharmaceuticals. In general, you should focus on analyzing Pieris Stock price patterns and their correlations with different microeconomic environments and drivers.
Pieris Pharmaceuticals Predictive Forecast Models
Pieris Pharmaceuticals' time-series forecasting models is one of many Pieris Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pieris Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pieris Pharmaceuticals
Checking the ongoing alerts about Pieris Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pieris Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pieris Pharmaceuticals generated a negative expected return over the last 90 days | |
| Pieris Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 42.81 M. Net Loss for the year was (24.54 M) with loss before overhead, payroll, taxes, and interest of (27.08 M). | |
| Pieris Pharmaceuticals currently holds about 80.94 M in cash with (53.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09. | |
| Pieris Pharmaceuticals has a poor financial position based on the latest SEC disclosures |
Additional Tools for Pieris Stock Analysis
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.